Platelet Function Changes as Monitored by Cone and Plate(let) Analyzer during Beating Heart Surgery
Background: Off-pump coronary artery bypass (OPCAB) is believed to reduce cardiopulmonary bypass (CPB)-related complications, including platelet damage. A hypercoagulable state instead of coagulopathy has been reported following OPCAB surgeries due to CPB. Whether platelet function is changed when the injurious effect of CPB is eliminated was investigated.
Methods: Platelet function was determined with the cone and plate(let) analyzer (CPA) method. The 2 parameters, average size (AS) and surface coverage (SC) of platelet aggregates, were measured with the CPA method to assess platelet aggregation and adhesion. These parameters were evaluated, and their values were compared at several stages of OPCAB surgery. The correlations of postoperative bleeding with platelet function at different stages of the surgery and with other factors, such as platelet count, hematocrit, and transfusions, were studied.
Results: Both AS and SC increased during several stages of the operation, and postoperative values (mean ± SD) were significantly higher than preoperative values (30.4 ± 8.1 m m2 versus 23.3 ± 6.9 m m2 for AS [P = .02] and 7.6% ± 3.6% versus 5.2% ± 1.8% for SC [P = .04]). The mean total bleeding volume was 875 ± 415 mL. Preoperative AS and SC were the only parameters significantly (P = .01) and linearly (r = 0.7) related to postoperative bleeding.
Conclusions: An increased platelet function, as determined by the CPA method, is found following OPCAB surgery. This phenomenon is probably at least partially responsible for the thrombogenic state after OPCAB surgery. Lack of platelet injury attributed to CPB may divert the system toward a more thrombogenic state. Preoperative platelet function, as evaluated by the CPA method, is an independent risk factor determining postoperative bleeding.
Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini SD. 2001. Reduced postoperative blood loss and transfusion requirement after beating heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 121:689-96.nCartier R, Robitaille D. 2001. Thrombotic complications in beating heart operations. J Thorac Cardiovasc Surg 121:920-2.nChandrasekar B, Tanguay JF. 2000. Platelets and restenosis. J Am Coll Cardiol 35:555-62.nColler BS. 1998. Monitoring platelet GP IIb/IIIa antagonist therapy. Circulation 97:5-9.nCollman RW. 1990. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 49:32-4.nDespotis GJ, Gravlee G, Filos K, Levy J. 1999. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91:1122-51.nFalciani M, Gori AM, Fedi S, et al. 1998. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease. Thromb Haemost 79:495-9.nKaboli P, Henderson MC, White RH. 2003. DVT prophylaxis and anticoagulation in the surgical patient. Med Clin North Am 87:77-110.nKenet G, Lubetsky A, Shenkman B, et al. 1998. Cone and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 101:255-9.nKroegel C, Reissig A. 2003. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 70:7-30.nLasne D, Fiemeyer A, Chatellier G, Chammas C, Baron JF, Aiach M. 2000. A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 84:794-9.nLevy JH, Smith PK. 2000. Platelet inhibitors and cardiac surgery. Ann Thorac Surg 70(suppl):S1-2.nMariani MA, Gu YJ, Boonstra PW, Grandjean JG, van Oeveren W, Ebels T. 1999. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 67:1370-5.nQuigley RL, Fried DW, Salenger R, Pym J, Highbloom RY. 2002. Thrombelastographic changes in OPCAB surgical patients. Perfusion 17:363-7.nShenkman B, Inbal A, Tamarin I, Lubetsky A, Savion N, Varon D. 2003. Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition. Br J Haematol 120:597-604.nShenkman B, Schneiderman J, Tamarin I, Kotev-Emeth S, Savion N, Varon D. 2001. Monitoring GPIIb-IIIa antagonist therapy in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods. Thromb Res 102:311-7.nvan Dijk D, Nierich AP, Jansen EW, et al. 2001. Early outcome after off-pump versus on-pump coronary bypass surgery. Circulation 104:1761-6.nStahl RF, Vander Salm TJ. 1996. Early postoperative care. In: Edmunds LH Jr, editor. Cardiac surgery in the adult. Columbus, Ohio: McGraw-Hill.nVaron D, Lashevski I, Brenner B, et al. 1998. Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. Am Heart J 135:S187-93.nWan S, LeClerc JL, Vincent JL. 1997. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112:676-92.nWeerasinghe A, Taylor KM. 1998. The platelets in cardiopulmonary bypass. Ann Thorac Surg 66:2145-52.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).